Diana Ernst, RPh

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

ATH434 is designed to reduce α-synuclein aggregation and oxidative stress by binding to and redistributing excess loosely bound iron in the brain.

BA-102 is an investigational agent that aims to target and regulate nitric oxide (NO) levels in the brain.

The approval for use in advanced neuroendocrine tumors is supported by data from the phase 3 CABINET trial.

Another phase 3 trial in MDD patients with EDS will begin sometime this year.

The Company is currently analyzing the case and will update the prescribing information for Elevidys to note this development.

The active ingredient in Zunveyl is benzgalantamine, a prodrug of galantamine, a competitive and reversible inhibitor of actylcholinesterase.

Cortrophin Gel is a purified adrenocorticotropic hormone.

Galzin is available exclusively through Optime Care, a specialty pharmacy.

Mirdametinib is an inhibitor of mitogen-activated protein kinase kinases 1 and 2.

Overall, the analysis showed lower stroke rates among female propranolol users at multiple timepoints.

Onapgo is a wearable subcutaneous infusion device that delivers apomorphine.

Worldwide, there have been 82 cases of anaphylaxis reported with glatiramer acetate use since December 1996.

Qelbree is a selective norepinephrine reuptake inhibitor.

There are currently no FDA-approved treatments for FXS, a disease that affects approximately 1 in 4-5000 men and 1 in 6-8000 women globally.

The approval was based on data from the double-blind, phase 3 SURMOUNT-OSA study.

Lumryz is supplied in packets with granules that are mixed with water to create an oral suspension.

At this time, there have been no reports of adverse events related to this recall.

The alert follows an announcement from the US DOJ regarding the indictment of 18 individuals who operated a network of fake online pharmacies and pill mills.

Alexander disease is a genetic disorder that affects astrocyte cells.

In the TEMPO-1 trial, participants with early PD were randomly assigned to receive tavapadon 5mg or 15mg once daily or placebo.

The over-the-counter medical application is intended for individuals aged 18 years and older who have not been previously diagnosed with sleep apnea.

FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.

The Epitomee capsule is a self-administered medical device that once ingested, expands in the stomach and occupies the space creating a sensation of fullness.

Substudy B of the MONeT trial assessed the safety and immunogenicity of Abrysvo in immunocompromised adults at risk of developing severe RSV-associated lower respiratory tract disease.

Nalmefene is an opioid antagonist that reverses the effects of natural and synthetic opioids.

The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.

The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.

Ahzantive is a vascular endothelial growth factor inhibitor.

Previously, the gene therapy had only been indicated under accelerated approval for ambulatory patients 4 through 5 years of age with DMD.